培元化瘀方治疗慢性硬膜下血肿临床观察  

Clinical Observation on Peiyuanhuayu Decoction for 31 Case with Chronic Subdural Hematomas

作　　者：范小璇[1] 赵晓平[1] 侯文[1] 柏鲁宁[1] 张毅[1] 周振国[1] 畅涛[1] 方永军[1] 

机构地区：[1]陕西中医学院附属医院,陕西咸阳712000

出　　处：《中国中医急症》2013年第12期2007-2008,共2页Journal of Emergency in Traditional Chinese Medicine

基　　金：陕西省科技统筹创新工程计划项目(2011KTCL03-02)

摘　　要：目的观察培元化瘀方在慢性硬膜下血肿术后的临床疗效。方法将31例患者随机分为治疗组(16例)和对照组(15例)。给予钻孔引流手术治疗后,对照组给予常规治疗,治疗组在常规治疗基础上第7日开始服用培元化瘀方进行治疗,分别观察比较两组患者的临床疗效、出血量和临床症状的变化。结果两组患者治疗均有效,治疗组较对照组痊愈患者居多(P<0.05),治疗后残余血量明显减少(P<0.05),治疗后眩晕症状改善明显(P<0.05)。结论培元化瘀方在慢性硬膜下血肿术后应用,对于改善临床症状,促进残余血量的吸收有明显的作用。Objective： To observe the clinical effect of Peiyuanhuayu Decoction with operation for chronic sub- dural hematomas（CSCD）. Methods： There were 31 patients with CSCD in our hospital,and were randomized into the treatment group（16 case） and control group （15 cases）. The treatment group was given conventional therapy and Peiyuanhuayu Decoction from the 7 th day to the 22 nd day after operation. The control group was given the conventional therapy after operation. The clinical effect,the amount of bleeding and the clinical symptoms were observed from the 7th day to the 22 nd day after operation. Results： 2 groups of treatment were effective. The re- covery of the treatment group was significantly more than that of the control group （P 〈 0.05）. The amount of bleeding of treatment group was much less than that of the control group（P〈 0.05）. The vertigo of treatment group improvement was more than that of the control group （P〈 0.05）. Conclusion： The effect of Peiyuanhuayu Decoc- tion is marked for CSCD after operation. It can promote the clinical symptoms and the hemorrhage cleanrance.

关 键 词：培元化瘀 慢性硬膜下血肿 手术治疗 

分 类 号：R651.15[医药卫生—外科学]